Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Actinium Pharmaceuticals Inc. (ATNM)

0.4641   -0.039 (-7.73%) 03-25 13:54
Open: 0.49 Pre. Close: 0.503
High: 0.5 Low: 0.44
Volume: 1,093,482 Market Cap: 54M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.533 - 0.539 0.539 - 0.542
Low: 0.48 - 0.486 0.486 - 0.49
Close: 0.493 - 0.503 0.503 - 0.509

Technical analysis

as of: 2019-03-25 1:28:11 PM
Overall:       
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 0.71     One year: 0.83
Support: Support1: 0.44    Support2: 0.37
Resistance: Resistance1: 0.61    Resistance2: 0.71
Pivot: 0.56
Moving Average: MA(5): 0.52     MA(20): 0.57
MA(100): 0.51     MA(250): 0.55
MACD: MACD(12,26): -0.01     Signal(9):
Stochastic oscillator: %K(14,3): 7.53     %D(3): 7.88
RSI: RSI(14): 31.35
52-week: High: 0.87  Low: 0.33  Change(%): 23.5
Average Vol(K): 3-Month: 77864  10-Days: 66806

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
ATNM has closed below the lower band by 11.9%. If price is in a downtrend band; this downward trend in price might continue. However a short term pullback inside the band is likely. Bollinger Bands are 3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Mon, 22 Oct 2018 14:07:36 Z
Has Actinium Pharmaceuticals (ATNM) Outpaced Other Medical Stocks This Year?

Tue, 09 Jan 2018 16:14:37 Z
PTC Therapeutics (PTCT) Jumps: Stock Rises 12.9%

Mon, 08 Jan 2018 18:02:41 Z
Zacks.com featured highlights include: Western Digital, Hecla Mining, Sphere 3D, Actinium Pharmaceuticals and Southern National Bancorp

Fri, 05 Jan 2018 14:11:51 Z
Beat the Market with Rising P/E Technique

Thu, 28 Dec 2017 17:15:29 Z
Actinium Posts Positive DMC View on Lomab-B Phase III Trial

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
atoplab.com
Tweet this page Share on Google+ Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 119.14
Shares Float (M) 118.71
% Held by Insiders 0.50
% Held by Institutions 12.40
Shares Short (K) 2798
Shares Short P. Month (K)

Stock Financials

EPS -0.100
EPS Est. Current Year -0.400
EPS Est. Next Year -0.250
EPS Est. Next Quarter -0.080
Forward EPS -0.090
Book Value (p.s.) 6.960
PEG Ratio
Profit Margin
Operating Margin
Return on Assets (ttm) -142.4
Return on Equity (ttm) -210.4
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) -19.45
Levered Free Cash Flow (M) -11.24

Stock Valuations

P/E -4.63
P/E Growth Ratio -0.08
P/BV 0.07
P/S
P/CF -2.84

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.